Rick Randall

Rick Randall is a seasoned medical device executive with experience as a CEO and Director in both publicly traded and privately held firms. They previously served as the CEO of Target Therapeutics, leading the development of the first transcatheter treatment for cerebral aneurysms, and were a pioneer in non-metallic tissue repair implants at Innovasive Devices. Currently, they work as Chief Executive Officer of Scientia Vascular and hold various director and advisory roles in emerging medical technology companies. Rick holds a BS in Science Education from Buffalo State University.